ReviewDrugs in context2021

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review.

Xenophon Kassianides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.